Takeda Pharmaceutical Co Ltd
F:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
Henry Schein Inc
NASDAQ:HSIC
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
B
|
Benchmark Electronics Inc
XMUN:BMU
|
US |
|
Marriott International Inc
NASDAQ:MAR
|
US |
|
L
|
Leju Holdings Ltd
F:1LUA
|
CN |
|
Arovella Therapeutics Ltd
F:E4NA
|
AU |
|
NXP Semiconductors NV
NASDAQ:NXPI
|
NL |
|
1911 Gold Corp
F:2KY
|
CA |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 29.34 EUR with a low forecast of 24.26 EUR and a high forecast of 37.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
29.34
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 29.34 EUR with a low forecast of 24.26 EUR and a high forecast of 37.83 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
